Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies.
Détails
ID Serval
serval:BIB_D7A4B8D24794
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies.
Périodique
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
ISSN
1548-8756 (Electronic)
ISSN-L
1548-8748
Statut éditorial
Publié
Date de publication
06/2024
Peer-reviewed
Oui
Volume
44
Numéro
3
Pages
e431608
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
Lifileucel or TIL has recently been FDA approved for metastatic melanoma patients as first cell therapy for a solid tumor. We discuss roll-out of TIL as new SOC and other upcoming new cell therapies.
Mots-clé
Humans, Melanoma/therapy, Immunotherapy, Adoptive/methods, Neoplasms/therapy, Treatment Outcome
Pubmed
Création de la notice
24/05/2024 8:41
Dernière modification de la notice
25/05/2024 6:14